课题基金 / 基金详情

PS23-003 - A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Cis-gender Black Women across Six Ending the HIV Epidemic Jurisdictions in the South

PS23-003 - A Community-based Assessment of Preferences for Long-Acting Antiretroviral Therapy Options Among Cis-gender Black Women across Six Ending the HIV Epidemic Jurisdictions in the South
PS23-003 - 基于社区的六个顺性别黑人女性对长效抗逆转录病毒治疗方案偏好的评估,结束南方艾滋病毒流行管辖区
批准号:
10812111
负责人:
Lauren Frances Collins
金额:
$33.29万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2023
资助国家:
美国
项目状态:
未结题
起止时间:
2023-09-01 至 2026-08-31

项目摘要

项目成果

Lauren Frances Collins的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT ABSTRACT Efforts to curb the HIV epidemic in the United States (US) are impeded by suboptimal access and adherence to antiretroviral therapy (ART), particularly among cis-gender Black women with HIV (CgBWH) in the Southern US who have lower care linkage, engagement, and viral suppression, and higher mortality, than their male and White female peers. Long-acting (LA) ART has the potential to transform the HIV treatment landscape, but the uptake of LA-injectable (LAI) ART has been low due to multi-level challenges and the lack of tailored approaches for key groups, including CgBWH. To help fill this gap, over the past six years our multidisciplinary team has led mixed methods research on women’s LA ART interest, preferences, barriers, and facilitators. However, these data were collected prior to LA ART approval, queried hypothetical use, and did not include young women or focus on the South. To realize the Ending the HIV Epidemic (EHE) initiative “Treat” pillar, we must develop novel approaches to optimize and tailor care linkage and ART adherence strategies for CgBWH. This proposal builds on our existing multisite research infrastructure and robust academic-community partnerships to explore Southern CgBWH preferences and implementation challenges in the era of approved LA ART; it will integrate stakeholders’ needs and values to co-create prototype tools for education, referral, and linkage to HIV treatment tailored to CgBWH. We will leverage the Study for Treatment And Reproductive Outcomes (STAR) infrastructure, that is currently enrolling 1200 CgBWH in six Southern sites including urban and rural EHE priority jurisdictions (AL, FL, GA, MS, NC, DC). To advance this work, we will use the Consolidated Framework for Implementation Research and Human-centered design to inform our data collection, analyses and the development of educational, referral, and linkage prototype toolkits to support CgBWH LA ART access and use. In Aim 1 we will examine CgBWH preferences, facilitators, and barriers to LA ART uptake and novel delivery via an ongoing LA ART survey in STAR (n=1200 CgBWH) and longitudinal interviews with 120 CgBWH who vary by adherence, LA ART use, age, and rurality. In Aim 2 we will identify strategies to equitably scale up LA ART for CgBWH through interviews with 60 HIV service providers including from community-based organizations (CBOs) that vary by role, LA ART availability, funding, and rurality. In Aim 3 we will use human-centered design approaches via a series of 3 workshops across four CBOs (2 rural, 2 urban) to integrate the voices of CgBWH and HIV service providers and iteratively develop LA ART educational, referral and linkage tools that are tailored, acceptable and feasible for CgBWH and a range of delivery sites. Given our established academic-community research infrastructure, clinical leadership in LA ART programming, and expertise in HIV and women’s health, qualitative methods and implementation science, we are well-positioned to rapidly implement this mixed methods study and disseminate knowledge to all stakeholders, thus addressing the EHE “Treat” pillar in HIV hotspots.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
An EYE toward healthy aging in HIV: building evidence for multimorbidity screening and prevention
  • 批准号:
    10762829
  • 项目类别:
  • 资助金额:
    $17.82万
  • 财政年份:
    2023
  • 负责人:
    Lauren Frances Collins
  • 依托单位:
国内基金
海外基金
SRSF3抑制剂SFI003逆转急性髓系白血病耐药性的功能与机制研究
  • 批准号:
    2026JJ60275
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
    邢程
  • 依托单位:
新型溶瘤性HPV治疗性疫苗MATV003的构建和药效学研究
  • 批准号:
    JCZRMS202601746
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2026
  • 负责人:
  • 依托单位:
基于JAK-STAT信号通路研究E003调控URSA的Th17/Treg免疫平衡的分子机制
  • 批准号:
    82360318
  • 项目类别:
    地区科学基金项目
  • 资助金额:
    31.00万元
  • 批准年份:
    2023
  • 负责人:
    章志琴
  • 依托单位:
噬菌体PaoP5编码蛋白Orf003通过FleQ抑制铜绿假单胞菌运动的分子机制研究